During the past decade, Bradenton Cardiology Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bradenton Cardiology Center" #1 sponsor was "Boston Scientific Corporation" with 7 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Medtronic" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bradenton Cardiology Center" #1 collaborator was "ClinLogix. LLC" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "BTG International Inc." with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator and "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Bradenton Cardiology Center" are "Critical Limb Ischemia" (2 trials), "Heart Failure" (2 trials), "Peripheral Arterial Disease" (2 trials), "Peripheral Vascular Disease" (2 trials) and "Arterial Occlusive Diseases" (1 trials). Many other conditions were trialed in "Bradenton Cardiology Center" in a lesser frequency.

Most popular intervention types in "Bradenton Cardiology Center" are "Device" (11 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amulet Left Atrial Appendage Occluder" (1 trials), "Arm 1 (ATP+Shock)" (1 trials), "Arm 2 (shock only)" (1 trials), "BioMimics 3D Vascular Stent System" (1 trials) and "Carotid WALLSTENT Monorail Endoprosthesis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bradenton Cardiology Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Bradenton Cardiology Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Bradenton Cardiology Center, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bradenton Cardiology Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".